Should recombinant human growth hormone therapy be used in short small for gestational age children?

Archives of Disease in Childhood

Volumn 89, Issue 8, 2004, Pages 740-744

  Johnston, L B ^a,b   Savage, M O ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BODY COMPOSITION; BODY GROWTH; CATCH UP GROWTH; CHILD; DRUG EFFECT; GROWTH ACCELERATION; GROWTH REGULATION; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; POSTNATAL GROWTH; PRIORITY JOURNAL; SAFETY; SMALL FOR DATE INFANT;

BODY COMPOSITION; BODY HEIGHT; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR I; RECOMBINANT PROTEINS; RISK FACTORS; TREATMENT OUTCOME;

EID: 3242887234     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.034785     Document Type: Article

References (42)

1. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995;38:733-9.
2. Lee PA, Chernausek SD, Hokken-Koelega AC, et al. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003;111(6 pt 1):1253-61.
3. Johnston LB, Clark AJ, Savage MO. Genetic factors contributing to birth weight. Arch Dis Child Fetal Neonatal Ed 2002;86:F2-3.
4. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, et al. Children born small for gestational age: do they catch up? Pediatr Res 1995;38:267-71.
5. Gibson AT, Carney S, Cavazzoni E, et al. Neonatal and post-natal growth. Horm Res 2000;53(suppl 1):42-9.
6. Deiber M, Chatelain P, Naville D, et al. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab 1989;68:232-4.
7. Ackland FM, Stanhope R, Eyre C, et al. Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation. Horm Res 1988;30:241-5.
8. Boguszewski M, Rosberg S, Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995;80:2599-606.
9. Giudice LC, de Zegher F, Gargasky SE, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-55.
10. Boguszewski M, Jansson C, Rosberg S, et al. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996;81:3902-8.
11. Rochiccioli P, Tauber M, Moisan V, et al. Investigation of growth hormone secretion in patients with intrauterine growth retardation. Acta Paediatr Scand Suppl 1989;349:42-6.
12. Sas T, de Waal W, Mulder P, et al. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 1999;84:3064-70.
13. Cianfarani S, Maiorana A, Geremia C, et al. Blood glucose concentrations are reduced in children born small far gestational age (SGA), and thyroid-stimulating hormone levels are increased in SGA with blunted postnatal catch-up growth. J Clin Endocrinol Metab 2003;88:2699-705.
14. Cianfarani S, Geremia C, Scott CD, et al. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res 2002;51:94-9.
15. Boguszewski M, Albertsson-Wikland K, Aronsson S, et al. Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial. Acta Paediatr 1998;87:257-63.
16. Van Pareren Y, Mulder P, Houdijk M, et al. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 2003;88:3584-90.
17. Chatelain P, Job JC, Blanchard J, et al. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. Belgian and French Pediatric Clinics and Sanofi-Choay (France). J Clin Endocrinol Metab 1994;78:1454-60.
18. Job JC, Chaussain JL, Job B, et al. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996;39:354-9.
19. Chatelain P, de Zegher F. Growth hormone treatment in children with intrauterine growth retardation and Silver-Russell syndrome. Growth hormone therapy in KIGS - 10 years' experience. Johann Ambrosius Barth Verlag 1999:305-19.
20. de Zegher F, Maes M, Gargosky SE, et al. High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab 1996;81:1887-92.
21. Ranke MB, Lindberg A. Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height. Acta Paediatr Suppl 1996;417:18-26.
22. de Zegher F, Du Caju MV, Heinrichs C, et al. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years. J Clin Endocrinol Metab 1999;84:1558-61.
23. Carel JC, Chatelain P, Rochiccioli P, et al. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab 2003;88:1587-93.
24. Zucchini S, Cacciari E, Balsamo A, et al. Final height of short subjects of low birth weight with and without growth hormone treatment. Arch Dis Child 2001;84:340-3.
25. Butenandt O, Lang G. Recombinant human growth hormone in short children born small for gestational age. German Study Group. J Pediatr Endocrinol Metab 1997;10:275-82.
26. Sas TC, Gerver WJ, De Bruin R, et al. Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial. Clin Endocrinol (Oxf) 2000;53:675-81.
27. Coutant R, Carel JC, Letrait M, et al. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 1998;83:1070-4.
28. Ranke MB, Lindberg A, Cowell CT, et al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 2003;88:125-31.
29. de Zegher F, Butenandt O, Chatelain P, et al. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years. Acta Paediatr Suppl 1997;423:207-12.
30. Sas T, Mulder P, Hokken-Koelega A. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab 2000;85:3786-92.
31. Leger J, Garel C, Fjellestad-Paulsen A, et al. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal. J Clin Endocrinol Metab 1998;83:3512-16.
32. Swerdlow AJ, Higgins CD, Adlard P, et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002;360:273-7.
33. Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-41.
34. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ 1997;315:341-7.
35. Yajnik CS, Fall CH, Vaidya U, et al. Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 1995;12:330-6.
36. Van Pareren Y, Mulder P, Houdijk M, et al. Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age. J Clin Endocrinol Metab 2003;88:347-53.
37. Soto N, Bazaes RA, Pena V, et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003;88:3645-50.
38. de Zegher F, Ong K, van Helvoirt M, et al. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 2002;87:148-51.
39. Cutfield WS, Jackson WE, Jefferies C, et al. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. J Pediatr 2003;142:113-16.
40. O'Keeffe MJ, O'Callaghan M, et al. Learning, cognitive, and attentional problems in adolescents born small for gestational age. Pediatrics 2003;112:301-7.
41. van der Reijden-Lakeman I, Slijper FM, Dongen-Melman JE, et al. Self-concept before and after two years of growth hormone treatment in intrauterine growth-retarded children. Horm Res 1996;46:88-94.
42. van der Reijden-Lakeman IE, de Sonneville LM, Swaab-Barneveld HJ, et al. Evaluation of attention before and after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Exp Neuropsychol 1997;19:101-18.